sb 239063 has been researched along with Anterior Choroidal Artery Infarction in 1 studies
SB 239063: structure in first source
SB-239063 : A member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Legos, JJ | 1 |
| Erhardt, JA | 1 |
| White, RF | 1 |
| Lenhard, SC | 1 |
| Chandra, S | 1 |
| Parsons, AA | 1 |
| Tuma, RF | 1 |
| Barone, FC | 1 |
1 other study available for sb 239063 and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia.
Topics: Animals; Cell Death; Cerebral Infarction; Enzyme Inhibitors; Imidazoles; Ischemic Attack, Transient; | 2001 |